Haematopoietic stem cell mobilisation and

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Previous treatment with haematopoietic stem cells gene therapy. Contraindications to the mobilisation and the myeloablative medicinal products must be considered. 4.4 Special warnings and precautions for use Traceability The traceability requirements of cell-based advanced therapy medicinal products must apply. To

  Cells, Stem, Haematopoietic, Mobilisation, Haematopoietic stem